Alx Oncology Holdings Inc
ALXO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001810182
In the last 90 days, Alx Oncology Holdings Inc insiders filed 0 open-market purchases and 2 sales; 93 institutions reported holding it in 13F filings for Q2 2026, worth $217.9M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Alx Oncology Holdings Inc changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 61 | 2 | 57 | −2 |
| Shares | 27.8M | 21.9K | 29.2M | +1.44M (+5.2%) |
| Value | $50.8M | $40.1K | $33.0M | −$17.8M (−35.0%) |
2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Alx Oncology Holdings Inc at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Seven Fleet Capital Management LP | 117,817 | $133.1K | 0.09% |
| Citadel Advisors LLC | 56,732 | $64.1K | 0.00% |
| Point72 Asset Management, L.P. | 20,217 | $22.8K | 0.00% |
| Nine Masts Capital Ltd | 15,475 | $17.5K | 0.00% |
| Virtu Financial LLC | 13,702 | $15.0K | 0.00% |
| Simplex Trading, LLC | 3,553 | $4.01K | 0.00% |
| Torren Management, LLC | 1,632 | $1.84K | 0.00% |
| Group One Trading, L.P. | 518 | $585 | 0.00% |
Sold out (10)
Institutions that held Alx Oncology Holdings Inc at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Ameriprise Financial Inc | 652,897 | $1.19M |
| Privium Fund Management B.V. | 509,059 | $931.6K |
| XTX Topco Ltd | 26,621 | $48.7K |
| HRT Financial LP | 22,535 | $41.0K |
| Qube Research & Technologies Ltd | 16,946 | $31.0K |
| AQR Capital Management LLC | 10,793 | $19.8K |
| Federated Hermes, Inc. | 2,374 | $4.34K |
| Citigroup Inc | 2,278 | $4.17K |
| EverSource Wealth Advisors, LLC | 499 | $913 |
| SRS Capital Advisors, Inc. | 2 | $3 |
Not filed for Q4 2025 yet (2)
Institutions that held Alx Oncology Holdings Inc at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Point72 Asia (Singapore) Pte. Ltd. | 13,907 | $25.4K |
| Cubist Systematic Strategies, LLC | 8,025 | $14.7K |